- Home
- INMB vs CNF Comparison
INMB vs CNF Comparison
Compare INMB & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INMB | CNF |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.3M | 33.9M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | INMB | CNF |
|---|---|---|
| Price | $1.20 | $3.90 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.87 | N/A |
| AVG Volume (30 Days) | ★ 467.6K | 6.0K |
| Earning Date | 05-07-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,000.00 | N/A |
| Revenue This Year | $264.29 | $252.34 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $0.37 |
| 52 Week High | $11.64 | $24.00 |
Technical Indicators
Market Signals| Indicator | INMB | CNF |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 35.13 |
| Support Level | $1.19 | $4.00 |
| Resistance Level | $1.48 | $5.13 |
| Average True Range (ATR) | 0.09 | 0.20 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 19.35 | 29.63 |
Price Performance
Historical ComparisonAbout INMB INmune Bio Inc.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.